SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-272144
Filing Date
2007-12-27
Accepted
2007-12-27 16:45:35
Documents
7
Period of Report
2007-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22339
2 LETTER AGREEMENT dex11.htm EX-1.1 81839
3 FORM OF WARRANT dex41.htm EX-4.1 57403
4 OPINION OF HELLER EHRMAN LLP dex51.htm EX-5.1 8153
5 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 113464
6 PRESS RELEASE dex991.htm EX-99.1 8320
7 GRAPHIC g66916001.jpg GRAPHIC 1923
  Complete submission text file 0001193125-07-272144.txt   295881
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 071329543
SIC: 2834 Pharmaceutical Preparations